Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes.

Belotserkovsky I, Brunner K, Pinaud L, Rouvinski A, Dellarole M, Baron B, Dubey G, Samassa F, Parsot C, Sansonetti P, Phalipon A.

MBio. 2018 Feb 13;9(1). pii: e02309-17. doi: 10.1128/mBio.02309-17.

2.

Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes.

Pinaud L, Samassa F, Porat Z, Ferrari ML, Belotserkovsky I, Parsot C, Sansonetti PJ, Campbell-Valois FX, Phalipon A.

Proc Natl Acad Sci U S A. 2017 Sep 12;114(37):9954-9959. doi: 10.1073/pnas.1707098114. Epub 2017 Aug 28.

3.

Escape of Actively Secreting Shigella flexneri from ATG8/LC3-Positive Vacuoles Formed during Cell-To-Cell Spread Is Facilitated by IcsB and VirA.

Campbell-Valois FX, Sachse M, Sansonetti PJ, Parsot C.

MBio. 2015 May 26;6(3):e02567-14. doi: 10.1128/mBio.02567-14.

4.

Distinct mutations led to inactivation of type 1 fimbriae expression in Shigella spp.

Bravo V, Puhar A, Sansonetti P, Parsot C, Toro CS.

PLoS One. 2015 Mar 26;10(3):e0121785. doi: 10.1371/journal.pone.0121785. eCollection 2015.

5.

B lymphocytes undergo TLR2-dependent apoptosis upon Shigella infection.

Nothelfer K, Arena ET, Pinaud L, Neunlist M, Mozeleski B, Belotserkovsky I, Parsot C, Dinadayala P, Burger-Kentischer A, Raqib R, Sansonetti PJ, Phalipon A.

J Exp Med. 2014 Jun 2;211(6):1215-29. doi: 10.1084/jem.20130914. Epub 2014 May 26.

6.

Structural basis for the inhibition of host protein ubiquitination by Shigella effector kinase OspG.

Grishin AM, Condos TE, Barber KR, Campbell-Valois FX, Parsot C, Shaw GS, Cygler M.

Structure. 2014 Jun 10;22(6):878-88. doi: 10.1016/j.str.2014.04.010. Epub 2014 May 22.

7.

A fluorescent reporter reveals on/off regulation of the Shigella type III secretion apparatus during entry and cell-to-cell spread.

Campbell-Valois FX, Schnupf P, Nigro G, Sachse M, Sansonetti PJ, Parsot C.

Cell Host Microbe. 2014 Feb 12;15(2):177-89. doi: 10.1016/j.chom.2014.01.005.

8.

Characterization of the promoter, MxiE box and 5' UTR of genes controlled by the activity of the type III secretion apparatus in Shigella flexneri.

Bongrand C, Sansonetti PJ, Parsot C.

PLoS One. 2012;7(3):e32862. doi: 10.1371/journal.pone.0032862. Epub 2012 Mar 12.

9.

The 33 carboxyl-terminal residues of Spa40 orchestrate the multi-step assembly process of the type III secretion needle complex in Shigella flexneri.

Botteaux A, Kayath CA, Page AL, Jouihri N, Sani M, Boekema E, Biskri L, Parsot C, Allaoui A.

Microbiology. 2010 Sep;156(Pt 9):2807-17. doi: 10.1099/mic.0.039651-0. Epub 2010 May 27.

PMID:
20507885
10.

Shigella type III secretion effectors: how, where, when, for what purposes?

Parsot C.

Curr Opin Microbiol. 2009 Feb;12(1):110-6. doi: 10.1016/j.mib.2008.12.002. Epub 2009 Jan 20. Review.

PMID:
19157960
11.

MxiC is secreted by and controls the substrate specificity of the Shigella flexneri type III secretion apparatus.

Botteaux A, Sory MP, Biskri L, Parsot C, Allaoui A.

Mol Microbiol. 2009 Jan;71(2):449-60. doi: 10.1111/j.1365-2958.2008.06537.x. Epub 2008 Nov 10.

12.

Structure of the Shigella T3SS effector IpaH defines a new class of E3 ubiquitin ligases.

Singer AU, Rohde JR, Lam R, Skarina T, Kagan O, Dileo R, Chirgadze NY, Cuff ME, Joachimiak A, Tyers M, Sansonetti PJ, Parsot C, Savchenko A.

Nat Struct Mol Biol. 2008 Dec;15(12):1293-301. doi: 10.1038/nsmb.1511. Epub 2008 Nov 9.

13.

Cell regulation.

Rothman-Denes LB, Parsot C.

Curr Opin Microbiol. 2008 Apr;11(2):75-7. doi: 10.1016/j.mib.2008.02.017. Epub 2008 Mar 21. No abstract available.

PMID:
18358764
14.

IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri.

Hachani A, Biskri L, Rossi G, Marty A, Ménard R, Sansonetti P, Parsot C, Van Nhieu GT, Bernardini ML, Allaoui A.

Microbes Infect. 2008 Mar;10(3):260-8. doi: 10.1016/j.micinf.2007.11.011. Epub 2007 Dec 8.

PMID:
18316224
15.

Type III secretion effectors of the IpaH family are E3 ubiquitin ligases.

Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C.

Cell Host Microbe. 2007 Mar 15;1(1):77-83.

16.

An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses.

Arbibe L, Kim DW, Batsche E, Pedron T, Mateescu B, Muchardt C, Parsot C, Sansonetti PJ.

Nat Immunol. 2007 Jan;8(1):47-56. Epub 2006 Dec 10.

PMID:
17159983
17.

IpaD is localized at the tip of the Shigella flexneri type III secretion apparatus.

Sani M, Botteaux A, Parsot C, Sansonetti P, Boekema EJ, Allaoui A.

Biochim Biophys Acta. 2007 Feb;1770(2):307-11. Epub 2006 Oct 18.

PMID:
17110044
18.

Transcriptional slippage controls production of type III secretion apparatus components in Shigella flexneri.

Penno C, Hachani A, Biskri L, Sansonetti P, Allaoui A, Parsot C.

Mol Microbiol. 2006 Dec;62(5):1460-8. Epub 2006 Oct 24.

19.

Structural mimicry for vinculin activation by IpaA, a virulence factor of Shigella flexneri.

Hamiaux C, van Eerde A, Parsot C, Broos J, Dijkstra BW.

EMBO Rep. 2006 Aug;7(8):794-9. Epub 2006 Jul 7.

21.

[Control of the host inflammatory response during Shigella flexneri infection].

Parsot C.

Med Sci (Paris). 2006 Jan;22(1):18-20. French. No abstract available.

22.

Shigella spp. and enteroinvasive Escherichia coli pathogenicity factors.

Parsot C.

FEMS Microbiol Lett. 2005 Nov 1;252(1):11-8. Epub 2005 Sep 15. Review.

23.

The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes.

Kim DW, Lenzen G, Page AL, Legrain P, Sansonetti PJ, Parsot C.

Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14046-51. Epub 2005 Sep 14.

24.

A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri.

Parsot C, Ageron E, Penno C, Mavris M, Jamoussi K, d'Hauteville H, Sansonetti P, Demers B.

Mol Microbiol. 2005 Jun;56(6):1627-35.

26.

Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri.

Le Gall T, Mavris M, Martino MC, Bernardini ML, Denamur E, Parsot C.

Microbiology. 2005 Mar;151(Pt 3):951-62.

PMID:
15758240
27.

Optimization of virulence functions through glucosylation of Shigella LPS.

West NP, Sansonetti P, Mounier J, Exley RM, Parsot C, Guadagnini S, Prévost MC, Prochnicka-Chalufour A, Delepierre M, Tanguy M, Tang CM.

Science. 2005 Feb 25;307(5713):1313-7.

28.

Structure of Spa15, a type III secretion chaperone from Shigella flexneri with broad specificity.

van Eerde A, Hamiaux C, Pérez J, Parsot C, Dijkstra BW.

EMBO Rep. 2004 May;5(5):477-83. Epub 2004 Apr 16.

29.

The evolutionary history of Shigella and enteroinvasive Escherichia coli revised.

Escobar-Páramo P, Giudicelli C, Parsot C, Denamur E.

J Mol Evol. 2003 Aug;57(2):140-8.

PMID:
14562958
31.

The various and varying roles of specific chaperones in type III secretion systems.

Parsot C, Hamiaux C, Page AL.

Curr Opin Microbiol. 2003 Feb;6(1):7-14. Review.

PMID:
12615213
32.

Identification of substrates and chaperone from the Yersinia enterocolitica 1B Ysa type III secretion system.

Foultier B, Troisfontaines P, Vertommen D, Marenne MN, Rider M, Parsot C, Cornelis GR.

Infect Immun. 2003 Jan;71(1):242-53.

34.

Chaperones of the type III secretion pathway: jacks of all trades.

Page AL, Parsot C.

Mol Microbiol. 2002 Oct;46(1):1-11. Review.

35.

Conversion of PtdIns(4,5)P(2) into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology.

Niebuhr K, Giuriato S, Pedron T, Philpott DJ, Gaits F, Sable J, Sheetz MP, Parsot C, Sansonetti PJ, Payrastre B.

EMBO J. 2002 Oct 1;21(19):5069-78.

36.

Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.

D'Hauteville H, Khan S, Maskell DJ, Kussak A, Weintraub A, Mathison J, Ulevitch RJ, Wuscher N, Parsot C, Sansonetti PJ.

J Immunol. 2002 May 15;168(10):5240-51.

37.

Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus.

Mavris M, Page AL, Tournebize R, Demers B, Sansonetti P, Parsot C.

Mol Microbiol. 2002 Mar;43(6):1543-53.

38.

Spa15 of Shigella flexneri, a third type of chaperone in the type III secretion pathway.

Page AL, Sansonetti P, Parsot C.

Mol Microbiol. 2002 Mar;43(6):1533-42.

39.

Characterization of the interaction partners of secreted proteins and chaperones of Shigella flexneri.

Page AL, Fromont-Racine M, Sansonetti P, Legrain P, Parsot C.

Mol Microbiol. 2001 Nov;42(4):1133-45.

40.
41.

Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery.

Subtil A, Parsot C, Dautry-Varsat A.

Mol Microbiol. 2001 Feb;39(3):792-800.

42.

Structure and composition of the Shigella flexneri "needle complex", a part of its type III secreton.

Blocker A, Jouihri N, Larquet E, Gounon P, Ebel F, Parsot C, Sansonetti P, Allaoui A.

Mol Microbiol. 2001 Feb;39(3):652-63.

43.

The virulence plasmid pWR100 and the repertoire of proteins secreted by the type III secretion apparatus of Shigella flexneri.

Buchrieser C, Glaser P, Rusniok C, Nedjari H, D'Hauteville H, Kunst F, Sansonetti P, Parsot C.

Mol Microbiol. 2000 Nov;38(4):760-71.

44.

IpgD, a protein secreted by the type III secretion machinery of Shigella flexneri, is chaperoned by IpgE and implicated in entry focus formation.

Niebuhr K, Jouihri N, Allaoui A, Gounon P, Sansonetti PJ, Parsot C.

Mol Microbiol. 2000 Oct;38(1):8-19.

45.

Characterization of the interaction of IpaB and IpaD, proteins required for entry of Shigella flexneri into epithelial cells, with a lipid membrane.

De Geyter C, Wattiez R, Sansonetti P, Falmagne P, Ruysschaert JM, Parsot C, Cabiaux V.

Eur J Biochem. 2000 Sep;267(18):5769-76.

46.

The development of a FACS-based strategy for the isolation of Shigella flexneri mutants that are deficient in intercellular spread.

Rathman M, Jouirhi N, Allaoui A, Sansonetti P, Parsot C, Tran Van Nhieu G.

Mol Microbiol. 2000 Mar;35(5):974-90.

47.

The tripartite type III secreton of Shigella flexneri inserts IpaB and IpaC into host membranes.

Blocker A, Gounon P, Larquet E, Niebuhr K, Cabiaux V, Parsot C, Sansonetti P.

J Cell Biol. 1999 Nov 1;147(3):683-93.

48.

SepA, the 110 kDa protein secreted by Shigella flexneri: two-domain structure and proteolytic activity.

Benjelloun-Touimi Z, Si Tahar M, Montecucco C, Sansonetti PJ, Parsot C.

Microbiology. 1998 Jul;144 ( Pt 7):1815-22.

PMID:
9695914
50.

Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation.

Bahrani FK, Sansonetti PJ, Parsot C.

Infect Immun. 1997 Oct;65(10):4005-10.

Supplemental Content

Loading ...
Support Center